Cargando…

HIV-1C env and gag Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana

HIV-1 compartmentalization in reservoir sites remains a barrier to complete HIV eradication. It is unclear whether there is variation in HIV-1 env and gag between cerebrospinal fluid (CSF) and plasma of individuals with HIV-associated cryptococcal meningitis (CM). We compared HIV-1 env characteristi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kelentse, Nametso, Moyo, Sikhulile, Mogwele, Mompati L., Ditshwanelo, Doreen, Mokaleng, Baitshepi, Moraka, Natasha O., Lechiile, Kwana, Leeme, Tshepo B., Lawrence, David S., Musonda, Rosemary, Kasvosve, Ishmael, Harrison, Thomas S., Jarvis, Joseph N., Gaseitsiwe, Simani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762280/ https://www.ncbi.nlm.nih.gov/pubmed/33297399 http://dx.doi.org/10.3390/v12121404

Ejemplares similares

Differences in human immunodeficiency virus-1C viral load and drug resistance mutation between plasma and cerebrospinal fluid in patients with human immunodeficiency virus-associated cryptococcal meningitis in Botswana
por: Kelentse, Nametso, et al.
Publicado: (2020)

Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana
por: Kelentse, Nametso, et al.
Publicado: (2022)

No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana
por: Mokaleng, Baitshepi, et al.
Publicado: (2023)

Comparison of an in-house ‘home-brew’ and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples
por: Seatla, Kaelo K., et al.
Publicado: (2019)

HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana †
por: Seatla, Kaelo K., et al.
Publicado: (2021)

HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads
por: Bareng, Ontlametse T, et al.
Publicado: (2022)

Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana
por: Rantshabeng, Patricia S., et al.
Publicado: (2017)

Prevalence of high-risk human papilloma virus in women with high-grade squamous cell intraepithelial lesions in Botswana using Abbott RealTime HPV assay
por: Rantshabeng, Patricia, et al.
Publicado: (2019)

Limited HIV-1 Subtype C nef 3′PPT Variation in Combination Antiretroviral Therapy Naïve and Experienced People Living with HIV in Botswana
por: Seatla, Kaelo K., et al.
Publicado: (2021)

Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana
por: Bareng, Ontlametse T., et al.
Publicado: (2022)

Genetic diversity of Mycobacterium tuberculosis strains circulating in Botswana
por: Mogashoa, Tuelo, et al.
Publicado: (2019)

Immune Phenotype and Functionality of Mtb-Specific T-Cells in HIV/TB Co-Infected Patients on Antiretroviral Treatment
por: Mupfumi, Lucy, et al.
Publicado: (2020)

Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana
por: Mupfumi, Lucy, et al.
Publicado: (2018)

Correction: Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana
por: Mupfumi, Lucy, et al.
Publicado: (2018)

Molecular detection of human papillomavirus (HPV) in highly fragmented DNA from cervical cancer biopsies using double-nested PCR
por: Tawe, Leabaneng, et al.
Publicado: (2018)

Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use
por: Maruapula, Dorcas, et al.
Publicado: (2023)

Predicted broadly neutralizing antibody (bnAb) resistance and associated envelope characteristics of adults with HIV-1 seroconversion in Botswana
por: Moraka, Natasha Onalenna, et al.
Publicado: (2023)

Predicted resistance to broadly neutralizing antibodies (bnAbs) and associated HIV-1 envelope characteristics among seroconverting adults in Botswana
por: Moraka, Natasha O., et al.
Publicado: (2023)

No Difference in Antibody Responses to Tetanus Vaccine Among HIV-Exposed and -Unexposed Infants in Botswana
por: Smith, Christiana, et al.
Publicado: (2017)

Atypical Hepatitis B Virus Serology Profile—Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative—In Hepatitis B Virus/HIV Coinfected Individuals in Botswana
por: Phinius, Bonolo B., et al.
Publicado: (2023)

Promoter Hypermethylation Analysis of Host Genes in Cervical Cancer Patients With and Without Human Immunodeficiency Virus in Botswana
por: Tawe, Leabaneng, et al.
Publicado: (2021)

Prevalence and molecular characterization of Hepatitis B in HIV infected individuals in Botswana
por: Anderson, Motswedi, et al.
Publicado: (2014)

2529. Child HIV Exposure and CMV Seroprevalence in Botswana: No Associations with 24-Month Growth and Neurodevelopment
por: Moraka, Natasha Onalenna, et al.
Publicado: (2019)

Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages
por: Novitsky, Vlad, et al.
Publicado: (2016)

Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana
por: Maseng, Monkgomotsi J, et al.
Publicado: (2021)

2572. Decreased T-Cell Response, but Appropriate Antibody Production to Tetanus Vaccine Among HIV-Exposed Uninfected Infants in Botswana
por: Smith, Christiana, et al.
Publicado: (2018)

Use of a mutation-specific genotyping method to assess for HIV-1 drug resistance in antiretroviral-naïve HIV-1 Subtype C-infected patients in Botswana
por: Maruapula, Dorcas, et al.
Publicado: (2021)

Prediction of Coreceptor Tropism in HIV-1 Subtype C in Botswana
por: Kotokwe, Kenanao, et al.
Publicado: (2023)

HIV-1 drug mutations in children from northern Tanzania
por: Shao, Elichilia R., et al.
Publicado: (2014)

Child HIV Exposure and CMV Seroprevalence in Botswana: No Associations With 24-Month Growth and Neurodevelopment
por: Moraka, Natasha O, et al.
Publicado: (2020)

The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes: Lessons from Botswana
por: Maseng, Monkgomotsi J., et al.
Publicado: (2022)

Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana
por: Moyo, Sikhulile, et al.
Publicado: (2016)

Genetic and epidemiological analysis of norovirus from children with gastroenteritis in Botswana, 2013–2015
por: Makhaola, Kgomotso, et al.
Publicado: (2018)

Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya
por: Tawe, Leabaneng, et al.
Publicado: (2022)

High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana
por: Ryan, Kathleen, et al.
Publicado: (2017)

Identifying Recent HIV Infections: From Serological Assays to Genomics
por: Moyo, Sikhulile, et al.
Publicado: (2015)

Coordinated changes of HIV-1 Gag and Env during assembly and maturation
por: Kräusslich, Hans-Georg
Publicado: (2013)

Pairwise diversity and tMRCA as potential markers for HIV infection recency
por: Moyo, Sikhulile, et al.
Publicado: (2017)

High Prevalence of Hepatitis B Virus Infection Among People With HIV in Rural and Periurban Communities in Botswana
por: Phinius, Bonolo B, et al.
Publicado: (2023)

The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana
por: N’Guessan, Kombo F, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_215ucecdjk6ejotn6u17pa0a3s